Back

Dyne Therapeutics shares rise 2.1% after positive DM1 trial results

Verifying
  • Dyne Therapeutics reported positive one-year functional data for experimental DM1 treatment z-basivarsen.
  • 25-26 pooled-dose participants improved video hand opening time by 3.2 seconds at six months.
  • Dyne continues targeting ACHIEVE topline data in the first quarter of 2027.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.